Bill Texts: NJ A277 | 2020-2021 | Regular Session

Bill Title: Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.

Spectrum: Partisan Bill (Democrat 6-0)

Status: (Passed) 2021-11-08 - Approved P.L.2021, c.285. [A277 Detail]

Bill Drafts

RevisionDateFormatSourceView
Chaptered2021-12-29HTML/TextLinkView
Amended2020-03-06HTML/TextLinkView
Introduced2020-01-14HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for New Jersey A277

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for New Jersey A277 currently on file.

Social Comments on NJ A277

feedback